CSIMarket
Bristol Myers Squibb Co  (BMY)
Other Ticker:  
 
 
 

Competition by BMY's Divisions

(Most recent Quarter in Millions of $)



COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY ABILIFY 46.0 0.0 -
Abbott Laboratories ABT Depakote 102.0 0.0 -
Eli Lilly And Company LLY Neurosciences 724.5 0.0 -
Johnson and Johnson JNJ RISPERDAL 501.0 0.0 -
Johnson and Johnson JNJ TOPAMAX 121.0 0.0 -
Merck and Co Inc MRK Other 5,797.0 0.0 -
Mylan N v MYL Total 2,972.1 185.7 6.25 %
Pfizer Inc PFE Central nervous system disorders 161.0 0.0 -
Merck and Co Inc MRK Maxalt 25.0 0.0 -
Johnson and Johnson JNJ INVEGA 321.0 0.0 -
APROX. MARKET   SUBTOTAL 10,771 186 1.72 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY SUSTIVA 333.0 0.0 -
Abbott Laboratories ABT Kaletra 250.0 0.0 -
Gilead Sciences Inc GILD HIV products Total 2,110.0 0.0 -
Abbvie Inc ABBV Kaletra 168.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Merck and Co Inc MRK Isentress 377.0 0.0 -
APROX. MARKET   SUBTOTAL 4,199 177 4.22 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY REYATAZ 0.0 0.0 -
Abbott Laboratories ABT Kaletra 250.0 0.0 -
Gilead Sciences Inc GILD HIV products Total 2,110.0 0.0 -
Abbvie Inc ABBV Kaletra 168.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Merck and Co Inc MRK Isentress 377.0 0.0 -
APROX. MARKET   SUBTOTAL 3,866 177 4.58 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY Avapro/Avalide 56.0 0.0 -
Abbott Laboratories ABT Other 572.0 0.0 -
Eli Lilly And Company LLY Cardiovascular 759.9 0.0 -
Mylan N v MYL Total 2,972.1 185.7 6.25 %
Pfizer Inc PFE Cardiovascular metabolic diseases 3,233.0 0.0 -
Merck and Co Inc MRK CozaarHyzaar 150.0 0.0 -
Merck and Co Inc MRK Zocor 56.0 0.0 -
Pfizer Inc PFE Cardiovascular & metabolic diseases 959.0 0.0 -
Merck and Co Inc MRK Zetia 633.0 0.0 -
Abbvie Inc ABBV Other 310.0 0.0 -
APROX. MARKET   SUBTOTAL 9,701 186 1.91 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY Taxol 0.0 0.0 -
APROX. MARKET   SUBTOTAL 0 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY Erbitux 167.0 0.0 -
APROX. MARKET   SUBTOTAL 167 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY Nutritionals 0.0 0.0 -
Johnson and Johnson JNJ Nutritionals 974.0 0.0 -
Pfizer Inc PFE Consumer Healthcare and Vaccines 817.0 0.0 -
Pfizer Inc PFE Consumer Healthcare 761.0 0.0 -
Abbott Laboratories ABT Nutritionals 1,789.0 459.0 25.66 %
Dupont De Nemours Inc DD Nutrition & Health 810.0 317.0 39.14 %
Fmc Corporation FMC FMC Health Nutrition 189.8 40.4 21.29 %
Balchem Corporation BCPC Total 197.9 25.0 12.64 %
APROX. MARKET   SUBTOTAL 5,539 841 15.19 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY PLAVIX 81.0 0.0 -
Pfizer Inc PFE Cardiovascular metabolic diseases 3,233.0 0.0 -
Pfizer Inc PFE Central nervous system disorders 161.0 0.0 -
Mylan N v MYL Total 2,972.1 185.7 6.25 %
Merck and Co Inc MRK CozaarHyzaar 150.0 0.0 -
Merck and Co Inc MRK Zocor 56.0 0.0 -
Pfizer Inc PFE Cardiovascular & metabolic diseases 959.0 0.0 -
Johnson and Johnson JNJ INVEGA 321.0 0.0 -
APROX. MARKET   SUBTOTAL 7,933 186 2.34 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY PRAVACHOL 0.0 0.0 -
Pfizer Inc PFE Cardiovascular metabolic diseases 3,233.0 0.0 -
Pfizer Inc PFE Central nervous system disorders 161.0 0.0 -
Mylan N v MYL Total 2,972.1 185.7 6.25 %
Merck and Co Inc MRK CozaarHyzaar 150.0 0.0 -
Merck and Co Inc MRK Zocor 56.0 0.0 -
Pfizer Inc PFE Cardiovascular & metabolic diseases 959.0 0.0 -
Johnson and Johnson JNJ INVEGA 321.0 0.0 -
APROX. MARKET   SUBTOTAL 7,852 186 2.36 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY ORENCIA 484.0 0.0 -
Biogen Inc BIIB PLEGRIDY 74.5 0.0 -
Johnson and Johnson JNJ REMICADE 3,268.0 0.0 -
Pfizer Inc PFE Arthritis & pain 212.0 0.0 -
Amgen Inc AMGN Aranesp TM-International 321.0 0.0 -
Amgen Inc AMGN Aranesp TM-U.S. 215.0 0.0 -
Amgen Inc AMGN ENBREL TM-International 67.0 0.0 -
Amgen Inc AMGN ENBREL TM-U.S. 991.0 0.0 -
Amgen Inc AMGN EPOGEN TM 978.0 0.0 -
Abbott Laboratories ABT HUMIRA 2,681.0 0.0 -
Amgen Inc AMGN ENBREL 1,459.0 0.0 -
Abbvie Inc ABBV HUMIRA 3,647.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Biogen Inc BIIB TECFIDERA 883.3 0.0 -
APROX. MARKET   SUBTOTAL 16,242 177 1.09 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY Other 1,842.0 0.0 -
Abbott Laboratories ABT HUMIRA 2,681.0 0.0 -
Johnson and Johnson JNJ REMICADE 3,268.0 0.0 -
Eli Lilly And Company LLY Oncology 861.3 0.0 -
Pfizer Inc PFE Oncology 279.0 0.0 -
Pfizer Inc PFE Arthritis & pain 212.0 0.0 -
Amgen Inc AMGN Aranesp TM-International 321.0 0.0 -
Amgen Inc AMGN Aranesp TM-U.S. 215.0 0.0 -
Abbvie Inc ABBV HUMIRA 3,647.0 0.0 -
Abbott Laboratories ABT Established Pharmaceutical Products 961.0 177.0 18.42 %
Johnson and Johnson JNJ VELCADE 683.0 0.0 -
APROX. MARKET   SUBTOTAL 14,970 177 1.18 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY SPRYCEL 411.0 0.0 -
Amgen Inc AMGN NEUPOGEN TM-International 64.0 0.0 -
Biogen Inc BIIB AVONEX 615.2 0.0 -
Biogen Inc BIIB TYSABRI 463.1 0.0 -
Johnson and Johnson JNJ PROCRIT 545.0 0.0 -
Amgen Inc AMGN NEUPOGEN TM-U.S. 268.0 0.0 -
Merck and Co Inc MRK Remicade 442.0 0.0 -
Alexion Pharmaceuticals Inc ALXN Total 1,636.5 489.2 29.89 %
APROX. MARKET   SUBTOTAL 4,445 489 11.01 %
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY BARACLUDE 320.0 0.0 -
Gilead Sciences Inc GILD Sovaldi 1,291.0 0.0 -
Gilead Sciences Inc GILD Harvoni 3,608.0 0.0 -
Abbvie Inc ABBV VIEKIRA 469.0 0.0 -
APROX. MARKET   SUBTOTAL 5,688 0 -
COMPANY NAME TICKER DIVISION NAME REVENUE INCOME MARGIN
Bristol Myers Squibb Co BMY Eliquis 466.0 0.0 -
Gilead Sciences Inc GILD Ranexa 141.0 0.0 -
Abbott Laboratories ABT Other 572.0 0.0 -
Eli Lilly And Company LLY Cardiovascular 759.9 0.0 -
Mylan N v MYL Total 2,972.1 185.7 6.25 %
Pfizer Inc PFE Cardiovascular metabolic diseases 3,233.0 0.0 -
Merck and Co Inc MRK CozaarHyzaar 150.0 0.0 -
Merck and Co Inc MRK Zocor 56.0 0.0 -
Pfizer Inc PFE Cardiovascular & metabolic diseases 959.0 0.0 -
Merck and Co Inc MRK Zetia 633.0 0.0 -
Merck and Co Inc MRK Januvia 1,014.0 0.0 -
Abbvie Inc ABBV Other 310.0 0.0 -
APROX. MARKET   SUBTOTAL 11,266 186 1.65 %





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ATSPU's Profile

Stock Price

ATSPU's Financials

Business Description

Fundamentals

Charts & Quotes

ATSPU's News

Suppliers

ATSPU's Competitors

Customers & Markets

Economic Indicators

ATSPU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071